Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. AN2 Therapeutics Inc shares valued at $1,911,410 were sold by Zakrzewski Joseph S on Jan 18 ’24. At $19.11 per share, Zakrzewski Joseph S sold 100,000 shares. The insider’s holdings dropped to 405,880 shares worth approximately $1.23 million following the completion of this transaction.
Also, Aziz Kabeer sold 100,000 shares, netting a total of over 1,965,000 in proceeds. Following the sale of shares at $19.65 each, the insider now holds 377,542 shares.
Before that, Adjuvant Global Health Technol had sold 84,093 shares from its account. In a trade valued at $1,652,427, the 10% Owner traded AN2 Therapeutics Inc shares for $19.65 each. Upon closing the transaction, the insider’s holdings decreased to 84,093 shares, worth approximately $6.07 million.
As published in a research note from JMP Securities on April 02, 2024, AN2 Therapeutics Inc [ANTX] has been rated up from a Mkt perform to a Mkt outperform and the price target has been revised to $6. Analysts at Leerink Partners downgraded the stock from ‘”an Outperform”‘ to ‘”a Market perform”‘ outlook in a report released in mid February. As of February 12, 2024, Oppenheimer has decreased its “an Outperform” rating to a “Perform” for ANTX. Earlier on February 12, 2024, JMP Securities downgraded its rating. Their new recommendation was “a Mkt perform” for ANTX stock which previously was a “a Mkt outperform”.
Analyzing ANTX Stock Performance
During the last five days, there has been a drop of approximately -9.79%. Over the course of the year, AN2 Therapeutics Inc shares have dropped approximately -85.16%. Shares of the company reached a 52-week high of $22.22 on 01/10/24 and a 52-week low of $2.72 on 03/06/24. A 50-day SMA is recorded $6.26, while a 200-day SMA reached $12.49. Nevertheless, trading volume fell to 1.67 million shares from 0.3 million shares the previous day.
Support And Resistance Levels for AN2 Therapeutics Inc (ANTX)
According to the 24-hour chart, there is a support level at 2.90, which, if violated, would cause prices to drop to 2.76. In the upper region, resistance lies at 3.18. The next price resistance is at 3.33. RSI (Relative Strength Index) is 30.49 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.20, which suggests the price will decrease in the coming days. Percent R is at 85.71%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
Is AN2 Therapeutics Inc subject to short interest?
Stocks of AN2 Therapeutics Inc saw a sharp steep in short interest on Mar 15, 2024 dropping by 16830.0 shares to 0.32 million. Data from Yahoo Finance shows that the short interest on Feb 15, 2024 was 0.34 million shares. A decline of -5.27% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 0.63 of the overall float, the days-to-cover ratio (short ratio) decline to 0.63.
